Associated Press reports on new UB-developed drug to treat cystic fibrosis

Drucy Borowitz, clinical professor of pediatrics and director of UB's cystic fibrosis program, is quoted in an Associated Press article about a new drug, the first of its kind, that treats the root cause of cystic fibrosis to improve lung function and reduce other symptoms in patients with a rare variant of the disease. "Even though this drug isn't for the majority of people, it proves that you can look at the mistake in the genes and design a drug in a rational way that will fix the problem," she said. The article appeared in news outlets that include NPR, The Washington Post, San Francisco Chronicle and CBS News.

Read more:

Drug approved to treat cystic fibrosis' root cause